Gohealth, Inc. (GOCO) — SEC Filings

Gohealth, Inc. (GOCO) — 25 SEC filings. Latest: 10-Q (Nov 14, 2025). Includes 14 8-K, 6 10-Q, 2 10-K.

View Gohealth, Inc. on SEC EDGAR

Overview

Gohealth, Inc. (GOCO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 14, 2025: GoHealth, Inc. reported a significant net loss of $313.9 million for the three months ended September 30, 2025, a stark contrast to the net income of $15.4 million in the prior-year period. This substantial loss was primarily driven by a massive $206.2 million indefinite and long-lived asset impairm

Sentiment Summary

Across 25 filings, the sentiment breakdown is: 2 bearish, 23 neutral. The dominant filing sentiment for Gohealth, Inc. is neutral.

Filing Type Overview

Gohealth, Inc. (GOCO) has filed 6 10-Q, 14 8-K, 1 DEF 14A, 2 10-K, 1 8-K/A, 1 DEFA14A with the SEC between Mar 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (25)

Gohealth, Inc. SEC Filing History
DateFormDescriptionRisk
Nov 14, 202510-QGoHealth Plunges to $314M Loss on Massive Asset Impairmenthigh
Nov 13, 20258-KGoHealth Files 8-K on Financialslow
Aug 19, 20258-KGoHealth, Inc. Announces Director Changes and Officer Compensationmedium
Aug 12, 202510-QGoHealth's Q2 Loss Doubles Amidst $53M Intangible Asset Impairmenthigh
Aug 7, 20258-K8-K Filing
Jun 30, 20258-KGoHealth, Inc. Files 8-K on New Material Agreementmedium
Jun 20, 20258-KGoHealth Files 8-K on Security Holder Vote Matterslow
May 16, 202510-QGoHealth Files Q1 2025 10-Qmedium
May 13, 20258-KGoHealth Files 8-K on Operations and Financialslow
Apr 28, 2025DEF 14AGoHealth Files Proxy Statement for June 18th Annual Meetinglow
Apr 7, 20258-KGoHealth Reports Director/Officer Changes & Financialsmedium
Feb 27, 202510-K10-K Filing
Nov 7, 202410-QGoHealth Files Q3 2024 Quarterly Reportlow
Oct 10, 20248-KGoHealth Announces Board and Executive Changesmedium
Oct 1, 20248-KGoHealth Files 8-K for September 30, 2024low
Sep 4, 20248-KGoHealth, Inc. Files 8-K for Regulation FD and Exhibitslow
Aug 8, 202410-QGoHealth Files Q2 2024 10-Qmedium
Jul 10, 20248-KGoHealth Appoints New Directorlow
Jun 25, 20248-KGoHealth CFO Departs; Interim Appointed, New Directors Electedmedium
Jun 21, 20248-K/AGoHealth, Inc. Amends 8-K: Director Changes and Compensationlow

Risk Profile

Risk Assessment: Of GOCO's 22 recent filings, 2 were flagged as high-risk, 9 as medium-risk, and 11 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Gohealth, Inc. Financial Summary (10-Q, Nov 14, 2025)
MetricValue
Revenue$34.2M
Net Income$-313.9M
EPS$-11.80
Operating Margin-842.2%
Total Assets$1.03B

Key Executives

  • Brandon Cruz
  • Clinton Jones
  • Steven Van Roekel
  • Robert L. Johnson
  • Steven J. Zazuli
  • Vincent Anania
  • Scott Woodworth
  • Steven Van Andel
  • David M. D. Smith
  • Patrick J. O'Malley
  • Michael J. P. Scarpino
  • Clinton M. "Clint" Jones
  • Patrick E. "Pat" Reidy

Industry Context

The health insurance industry, particularly the Medicare Advantage and ACA marketplaces, is characterized by intense competition and evolving regulatory landscapes. Companies like GoHealth act as intermediaries, connecting consumers with insurance plans offered by third-party carriers. Success hinges on effective marketing, robust technology platforms, and strong relationships with insurers.

Top Tags

financials (4) · financial-reporting (3) · sec-filing (3) · governance (3) · quarterly-report (3) · Revenue Decline (2) · Net Loss (2) · director-change (2) · Insurance Brokerage (2) · 8-k (2)

Key Numbers

Gohealth, Inc. Key Metrics
MetricValueContext
Net Loss$313.9Mfor Q3 2025, a significant decline from $15.4M net income in Q3 2024
Asset Impairment Charges$206.2Mprimary driver of the net loss in Q3 2025
Net Revenues$34.2Mfor Q3 2025, a 71% decrease from $118.3M in Q3 2024
Net Loss (YTD)$439.7Mfor the nine months ended September 30, 2025, compared to $65.3M loss in prior year
Total Assets$1.03Bas of September 30, 2025, down from $1.49B at December 31, 2024
Loss per Share (Basic)$11.80for Q3 2025, compared to $0.58 income per share in Q3 2024
Revenue Decrease71%quarter-over-quarter decline in net revenues
Interest Expense$24.8Mfor Q3 2025, an increase from $19.1M in Q3 2024
Net revenues for Q2 2025$94.048MDecreased from $105.870 million in Q2 2024, a 11.2% decline.
Net loss for Q2 2025$115.989MIncreased from $59.314 million in Q2 2024, a 95.5% increase in loss.
Intangible asset impairment charges for Q2 2025$53.000MA new charge in Q2 2025, significantly contributing to the net loss.
Total operating expenses for Q2 2025$193.434MIncreased from $146.480 million in Q2 2024, a 32.1% rise.
Total assets as of June 30, 2025$1.311BDecreased from $1.488 billion as of December 31, 2024, a 11.9% reduction.
Long-term debt as of June 30, 2025$560.003MIncreased from $447.865 million as of December 31, 2024, a 25.0% increase.
Net loss per share of Class A common stock for Q2 2025$5.10Increased from $2.70 in Q2 2024, indicating a worsening per-share performance.

Frequently Asked Questions

What are the latest SEC filings for Gohealth, Inc. (GOCO)?

Gohealth, Inc. has 25 recent SEC filings from Mar 2024 to Nov 2025, including 14 8-K, 6 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of GOCO filings?

Across 25 filings, the sentiment breakdown is: 2 bearish, 23 neutral. The dominant sentiment is neutral.

Where can I find Gohealth, Inc. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Gohealth, Inc. (GOCO) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Gohealth, Inc.?

Key financial highlights from Gohealth, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for GOCO?

The investment thesis for GOCO includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Gohealth, Inc.?

Key executives identified across Gohealth, Inc.'s filings include Brandon Cruz, Clinton Jones, Steven Van Roekel, Robert L. Johnson, Steven J. Zazuli and 8 others.

What are the main risk factors for Gohealth, Inc. stock?

Of GOCO's 22 assessed filings, 2 were flagged high-risk, 9 medium-risk, and 11 low-risk.

What are recent predictions and forward guidance from Gohealth, Inc.?

Forward guidance and predictions for Gohealth, Inc. are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.